img

Global Insomnia Therapy Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Insomnia Therapy Market Insights, Forecast to 2034

Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.
Market Analysis and InsightsGlobal Insomnia Therapy Market
Global Insomnia Therapy market is expected to reach to US$ 3060 million in 2023, with a positive growth of %, compared with US$ 2900 million in 2022. Backed with the increasing demand from downstream industries, Insomnia Therapy industry is evaluated to reach US$ 4147.8 million in 2033. The CAGR will be 5.2% during 2023 to 2033.
The growth of the global insomnia market size is majorly driven by the increase in prevalence of different types of sleep disorders, such as insomnia and parasomnias, increase in mental depression, and other painful conditions. Mental depression results in difficulty in sleep. For instance, the World Health Organization (WHO) reported that around 280 million population globally suffers from depression. Thus, increase in mental depression across the global population contributes in the insomnia market growth.
Report Covers
This report presents an overview of global Insomnia Therapy market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Insomnia Therapy market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Segment by Type
Non-pharmacological Therapy
Pharmacological Therapy

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Insomnia Therapy introduction, etc. Insomnia Therapy Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Insomnia Therapy
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Non-pharmacological Therapy
1.2.3 Pharmacological Therapy
1.3 Market by Application
1.3.1 Global Insomnia Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapy Market Perspective (2018-2033)
2.2 Global Insomnia Therapy Growth Trends by Region
2.2.1 Insomnia Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Insomnia Therapy Historic Market Size by Region (2018-2023)
2.2.3 Insomnia Therapy Forecasted Market Size by Region (2024-2033)
2.3 Insomnia Therapy Market Dynamics
2.3.1 Insomnia Therapy Industry Trends
2.3.2 Insomnia Therapy Market Drivers
2.3.3 Insomnia Therapy Market Challenges
2.3.4 Insomnia Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Insomnia Therapy by Players
3.1.1 Global Insomnia Therapy Revenue by Players (2018-2023)
3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Insomnia Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Insomnia Therapy Market Concentration Ratio
3.4.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2022
3.5 Global Key Players of Insomnia Therapy Head office and Area Served
3.6 Global Key Players of Insomnia Therapy, Product and Application
3.7 Global Key Players of Insomnia Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapy Breakdown Data by Type
4.1 Global Insomnia Therapy Historic Market Size by Type (2018-2023)
4.2 Global Insomnia Therapy Forecasted Market Size by Type (2024-2033)
5 Insomnia Therapy Breakdown Data by Application
5.1 Global Insomnia Therapy Historic Market Size by Application (2018-2023)
5.2 Global Insomnia Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Insomnia Therapy Market Size (2018-2033)
6.2 North America Insomnia Therapy Market Size by Type
6.2.1 North America Insomnia Therapy Market Size by Type (2018-2023)
6.2.2 North America Insomnia Therapy Market Size by Type (2024-2033)
6.2.3 North America Insomnia Therapy Market Share by Type (2018-2033)
6.3 North America Insomnia Therapy Market Size by Application
6.3.1 North America Insomnia Therapy Market Size by Application (2018-2023)
6.3.2 North America Insomnia Therapy Market Size by Application (2024-2033)
6.3.3 North America Insomnia Therapy Market Share by Application (2018-2033)
6.4 North America Insomnia Therapy Market Size by Country
6.4.1 North America Insomnia Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Insomnia Therapy Market Size by Country (2018-2023)
6.4.3 North America Insomnia Therapy Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Insomnia Therapy Market Size (2018-2033)
7.2 Europe Insomnia Therapy Market Size by Type
7.2.1 Europe Insomnia Therapy Market Size by Type (2018-2023)
7.2.2 Europe Insomnia Therapy Market Size by Type (2024-2033)
7.2.3 Europe Insomnia Therapy Market Share by Type (2018-2033)
7.3 Europe Insomnia Therapy Market Size by Application
7.3.1 Europe Insomnia Therapy Market Size by Application (2018-2023)
7.3.2 Europe Insomnia Therapy Market Size by Application (2024-2033)
7.3.3 Europe Insomnia Therapy Market Share by Application (2018-2033)
7.4 Europe Insomnia Therapy Market Size by Country
7.4.1 Europe Insomnia Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Insomnia Therapy Market Size by Country (2018-2023)
7.4.3 Europe Insomnia Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Insomnia Therapy Market Size (2018-2033)
8.2 China Insomnia Therapy Market Size by Type
8.2.1 China Insomnia Therapy Market Size by Type (2018-2023)
8.2.2 China Insomnia Therapy Market Size by Type (2024-2033)
8.2.3 China Insomnia Therapy Market Share by Type (2018-2033)
8.3 China Insomnia Therapy Market Size by Application
8.3.1 China Insomnia Therapy Market Size by Application (2018-2023)
8.3.2 China Insomnia Therapy Market Size by Application (2024-2033)
8.3.3 China Insomnia Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Insomnia Therapy Market Size (2018-2033)
9.2 Asia Insomnia Therapy Market Size by Type
9.2.1 Asia Insomnia Therapy Market Size by Type (2018-2023)
9.2.2 Asia Insomnia Therapy Market Size by Type (2024-2033)
9.2.3 Asia Insomnia Therapy Market Share by Type (2018-2033)
9.3 Asia Insomnia Therapy Market Size by Application
9.3.1 Asia Insomnia Therapy Market Size by Application (2018-2023)
9.3.2 Asia Insomnia Therapy Market Size by Application (2024-2033)
9.3.3 Asia Insomnia Therapy Market Share by Application (2018-2033)
9.4 Asia Insomnia Therapy Market Size by Region
9.4.1 Asia Insomnia Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Insomnia Therapy Market Size by Region (2018-2023)
9.4.3 Asia Insomnia Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Insomnia Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Insomnia Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Insomnia Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Insomnia Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Insomnia Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Insomnia Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Insomnia Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Insomnia Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Insomnia Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Insomnia Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Insomnia Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Insomnia Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Insomnia Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Details
11.1.2 Merck & Co. Business Overview
11.1.3 Merck & Co. Insomnia Therapy Introduction
11.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2018-2023)
11.1.5 Merck & Co. Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Insomnia Therapy Introduction
11.2.4 Sanofi Revenue in Insomnia Therapy Business (2018-2023)
11.2.5 Sanofi Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Insomnia Therapy Introduction
11.3.4 Pfizer Revenue in Insomnia Therapy Business (2018-2023)
11.3.5 Pfizer Recent Developments
11.4 Takeda Pharmaceutical Company Ltd.
11.4.1 Takeda Pharmaceutical Company Ltd. Company Details
11.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
11.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2018-2023)
11.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments
11.5 Purdue Pharmaceuticals L.P.
11.5.1 Purdue Pharmaceuticals L.P. Company Details
11.5.2 Purdue Pharmaceuticals L.P. Business Overview
11.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
11.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2018-2023)
11.5.5 Purdue Pharmaceuticals L.P. Recent Developments
11.6 Eisai, Co. Ltd.
11.6.1 Eisai, Co. Ltd. Company Details
11.6.2 Eisai, Co. Ltd. Business Overview
11.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
11.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2018-2023)
11.6.5 Eisai, Co. Ltd. Recent Developments
11.7 Meda Consumer Healthcare
11.7.1 Meda Consumer Healthcare Company Details
11.7.2 Meda Consumer Healthcare Business Overview
11.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
11.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2018-2023)
11.7.5 Meda Consumer Healthcare Recent Developments
11.8 Pernix Therapeutics
11.8.1 Pernix Therapeutics Company Details
11.8.2 Pernix Therapeutics Business Overview
11.8.3 Pernix Therapeutics Insomnia Therapy Introduction
11.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2018-2023)
11.8.5 Pernix Therapeutics Recent Developments
11.9 Vanda Pharmaceuticals
11.9.1 Vanda Pharmaceuticals Company Details
11.9.2 Vanda Pharmaceuticals Business Overview
11.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
11.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2018-2023)
11.9.5 Vanda Pharmaceuticals Recent Developments
11.10 ECR Pharmaceuticals
11.10.1 ECR Pharmaceuticals Company Details
11.10.2 ECR Pharmaceuticals Business Overview
11.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
11.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2018-2023)
11.10.5 ECR Pharmaceuticals Recent Developments
11.11 Fidia Farmaceutici
11.11.1 Fidia Farmaceutici Company Details
11.11.2 Fidia Farmaceutici Business Overview
11.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
11.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2018-2023)
11.11.5 Fidia Farmaceutici Recent Developments
11.12 Dainippon Sumitomo
11.12.1 Dainippon Sumitomo Company Details
11.12.2 Dainippon Sumitomo Business Overview
11.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
11.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2018-2023)
11.12.5 Dainippon Sumitomo Recent Developments
11.13 Biocodex
11.13.1 Biocodex Company Details
11.13.2 Biocodex Business Overview
11.13.3 Biocodex Insomnia Therapy Introduction
11.13.4 Biocodex Revenue in Insomnia Therapy Business (2018-2023)
11.13.5 Biocodex Recent Developments
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Details
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Insomnia Therapy Introduction
11.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2018-2023)
11.14.5 Eli Lilly and Company Recent Developments
11.15 Ebb Therapeutics
11.15.1 Ebb Therapeutics Company Details
11.15.2 Ebb Therapeutics Business Overview
11.15.3 Ebb Therapeutics Insomnia Therapy Introduction
11.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2018-2023)
11.15.5 Ebb Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Insomnia Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Non-pharmacological Therapy
Table 3. Key Players of Pharmacological Therapy
Table 4. Global Insomnia Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Insomnia Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Insomnia Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Insomnia Therapy Market Share by Region (2018-2023)
Table 8. Global Insomnia Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Insomnia Therapy Market Share by Region (2024-2033)
Table 10. Insomnia Therapy Market Trends
Table 11. Insomnia Therapy Market Drivers
Table 12. Insomnia Therapy Market Challenges
Table 13. Insomnia Therapy Market Restraints
Table 14. Global Insomnia Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Insomnia Therapy Revenue Share by Players (2018-2023)
Table 16. Global Top Insomnia Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2022)
Table 17. Global Insomnia Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Insomnia Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Insomnia Therapy, Headquarters and Area Served
Table 20. Global Key Players of Insomnia Therapy, Product and Application
Table 21. Global Key Players of Insomnia Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Insomnia Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Insomnia Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Insomnia Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Insomnia Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Insomnia Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Insomnia Therapy Revenue Share by Application (2018-2023)
Table 29. Global Insomnia Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Insomnia Therapy Revenue Share by Application (2024-2033)
Table 31. North America Insomnia Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Insomnia Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Insomnia Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Insomnia Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Insomnia Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Insomnia Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Insomnia Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Insomnia Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Insomnia Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Insomnia Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Insomnia Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Insomnia Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Insomnia Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Insomnia Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Insomnia Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Insomnia Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Insomnia Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Insomnia Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Insomnia Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Insomnia Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Insomnia Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Insomnia Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Insomnia Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Insomnia Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Insomnia Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Insomnia Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Insomnia Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Insomnia Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Insomnia Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Insomnia Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Insomnia Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Insomnia Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 63. Merck & Co. Company Details
Table 64. Merck & Co. Business Overview
Table 65. Merck & Co. Insomnia Therapy Product
Table 66. Merck & Co. Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 67. Merck & Co. Recent Developments
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Insomnia Therapy Product
Table 71. Sanofi Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 72. Sanofi Recent Developments
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Insomnia Therapy Product
Table 76. Pfizer Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 77. Pfizer Recent Developments
Table 78. Takeda Pharmaceutical Company Ltd. Company Details
Table 79. Takeda Pharmaceutical Company Ltd. Business Overview
Table 80. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product
Table 81. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 82. Takeda Pharmaceutical Company Ltd. Recent Developments
Table 83. Purdue Pharmaceuticals L.P. Company Details
Table 84. Purdue Pharmaceuticals L.P. Business Overview
Table 85. Purdue Pharmaceuticals L.P. Insomnia Therapy Product
Table 86. Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 87. Purdue Pharmaceuticals L.P. Recent Developments
Table 88. Eisai, Co. Ltd. Company Details
Table 89. Eisai, Co. Ltd. Business Overview
Table 90. Eisai, Co. Ltd. Insomnia Therapy Product
Table 91. Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 92. Eisai, Co. Ltd. Recent Developments
Table 93. Meda Consumer Healthcare Company Details
Table 94. Meda Consumer Healthcare Business Overview
Table 95. Meda Consumer Healthcare Insomnia Therapy Product
Table 96. Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 97. Meda Consumer Healthcare Recent Developments
Table 98. Pernix Therapeutics Company Details
Table 99. Pernix Therapeutics Business Overview
Table 100. Pernix Therapeutics Insomnia Therapy Product
Table 101. Pernix Therapeutics Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 102. Pernix Therapeutics Recent Developments
Table 103. Vanda Pharmaceuticals Company Details
Table 104. Vanda Pharmaceuticals Business Overview
Table 105. Vanda Pharmaceuticals Insomnia Therapy Product
Table 106. Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 107. Vanda Pharmaceuticals Recent Developments
Table 108. ECR Pharmaceuticals Company Details
Table 109. ECR Pharmaceuticals Business Overview
Table 110. ECR Pharmaceuticals Insomnia Therapy Product
Table 111. ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 112. ECR Pharmaceuticals Recent Developments
Table 113. Fidia Farmaceutici Company Details
Table 114. Fidia Farmaceutici Business Overview
Table 115. Fidia Farmaceutici Insomnia Therapy Product
Table 116. Fidia Farmaceutici Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 117. Fidia Farmaceutici Recent Developments
Table 118. Dainippon Sumitomo Company Details
Table 119. Dainippon Sumitomo Business Overview
Table 120. Dainippon Sumitomo Insomnia Therapy Product
Table 121. Dainippon Sumitomo Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 122. Dainippon Sumitomo Recent Developments
Table 123. Biocodex Company Details
Table 124. Biocodex Business Overview
Table 125. Biocodex Insomnia Therapy Product
Table 126. Biocodex Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 127. Biocodex Recent Developments
Table 128. Eli Lilly and Company Company Details
Table 129. Eli Lilly and Company Business Overview
Table 130. Eli Lilly and Company Insomnia Therapy Product
Table 131. Eli Lilly and Company Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 132. Eli Lilly and Company Recent Developments
Table 133. Ebb Therapeutics Company Details
Table 134. Ebb Therapeutics Business Overview
Table 135. Ebb Therapeutics Insomnia Therapy Product
Table 136. Ebb Therapeutics Revenue in Insomnia Therapy Business (2018-2023) & (US$ Million)
Table 137. Ebb Therapeutics Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Insomnia Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Insomnia Therapy Market Share by Type: 2022 VS 2033
Figure 3. Non-pharmacological Therapy Features
Figure 4. Pharmacological Therapy Features
Figure 5. Global Insomnia Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Insomnia Therapy Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Insomnia Therapy Report Years Considered
Figure 11. Global Insomnia Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Insomnia Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Insomnia Therapy Market Share by Region: 2022 VS 2033
Figure 14. Global Insomnia Therapy Market Share by Players in 2022
Figure 15. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Insomnia Therapy Revenue in 2022
Figure 17. North America Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Insomnia Therapy Market Share by Type (2018-2033)
Figure 19. North America Insomnia Therapy Market Share by Application (2018-2033)
Figure 20. North America Insomnia Therapy Market Share by Country (2018-2033)
Figure 21. United States Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Insomnia Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Insomnia Therapy Market Share by Type (2018-2033)
Figure 25. Europe Insomnia Therapy Market Share by Application (2018-2033)
Figure 26. Europe Insomnia Therapy Market Share by Country (2018-2033)
Figure 27. Germany Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Insomnia Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Insomnia Therapy Market Share by Type (2018-2033)
Figure 35. China Insomnia Therapy Market Share by Application (2018-2033)
Figure 36. Asia Insomnia Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Insomnia Therapy Market Share by Type (2018-2033)
Figure 38. Asia Insomnia Therapy Market Share by Application (2018-2033)
Figure 39. Asia Insomnia Therapy Market Share by Region (2018-2033)
Figure 40. Japan Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Insomnia Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Insomnia Therapy Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Insomnia Therapy Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Insomnia Therapy Market Share by Country (2018-2033)
Figure 50. Brazil Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Insomnia Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Merck & Co. Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 57. Sanofi Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 59. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 60. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 61. Eisai, Co. Ltd. Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 62. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 63. Pernix Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 64. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 65. ECR Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 66. Fidia Farmaceutici Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 67. Dainippon Sumitomo Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 68. Biocodex Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 69. Eli Lilly and Company Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 70. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed